Biopharm Company News - BioPharm International

ADVERTISEMENT

Biopharm Company News
News from biopharmaceutical companies, including mergers, acquisitions, drug approvals, drug recalls.

Roche to Acquire Seragon Pharmaceuticals

July 2, 2014

Genentech's $1.7 billion acquisition of Seargon Pharmaceutical includes portfolio of investigational next-generation oral selective estrogen receptor degraders.

PlantForm and PharmaPraxis Establish Joint Biosimilar Development Venture

July 2, 2014

PlantForm and PharmaPraxis announce plans to develop six biopharmaceutical targets for the Brazilian market.

BMS Recalls Coumadin Vials Due to Particulate Matter

July 1, 2014

Bristol-Myers Squibb issues a voluntary US recall of Coumadin (warfarin sodium) for injection due to presence of particulate matter.

Merck Collaborates with Bionomics on Alzheimer's Treatments

July 1, 2014

Merck funds Bionomics with $20 million to progress therapies for cognitive impairment caused by central nervous system disorders

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates

July 1, 2014

The collaboration will use Mersana Therapeutics Fleximer technology for antibody-drug conjugates.

Cytovance Biologics Manufactures AM0010 for ARMO BioSciences

June 29, 2014

Cytovance Biologics completes GMP manufacture of ARMO BioSciences' lead product.

GSK Offers $1 Million Award for Healthcare Innovations

June 29, 2014

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world"s poorest children.

Medicenna Therapeutics Selects Kalon Biotherapeutics To Manufacture New Cancer Drug

June 26, 2014

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Shire Confirms Rejection of AbbVie Proposal

June 20, 2014

Shire reports that AbbVie offer undervalued company.

ADVERTISEMENT

ADVERTISEMENT

Click here